Congressional Research Service Reports - 328 Matching Results

Search Results

National Environmental Education Act of 1990: Overview, Implementation, and Issues for Congress: This report summarizes major provisions of the National Environmental Education Act of 1990, discusses appropriations for activities authorized in that statute, examines the implementation of these activities, and analyzes key issues and relevant legislation.
Technology Transfer: Use of Federally Funded Research and Development: This report discusses the federal use of technology transfer, a process by which technology developed in one organization, in one area, or for one purpose is applied in another organization, in another area, or for another purpose.
Federal Research and Development Funding: FY2007: This report discusses federal research and development (R&D) funding. As in the recent past, the FY2007 increase over the FY2006 estimated funding levels is due to significant funding increases in the Department of Defense (DOD) and the National Aeronautics and Space Administration's (NASA's) space vehicles development program.
National Environmental Education Act of 1990: Overview, Implementation, and Reauthorization Issues: This report presents an overview of the National Environmental Education Act of 1990, discusses appropriations, examines the Environmental Protection Agency's (EPA's) implementation of the act, and analyzes reauthorization issues relevant to legislation introduced in recent Congresses.
U.S. National Science Foundation: Experimental Program to Stimulate Competitive Research (EPSCoR): This report discusses current policy involving The Experimental Program to Stimulate Competitive Research (EPSCoR), as well as budget requests.
Technology Transfer: Use of Federally Funded Research and Development: This report discusses the federal use of technology transfer, a process by which technology developed in one organization, in one area, or for one purpose is applied in another organization, in another area, or for another purpose.
The President's Office of Science and Technology Policy: Issues for Congress: This report provides an overview of the history of science and technology (S&T) advice to the President and discusses selected issues and options for Congress regarding the Office of Science and Technology Policy (OSTP) Director, OSTP management and operations, the President's Council of Advisors on Science and Technology (PCAST), and the National Science and Technology Council (NSTC).
How to Develop and Write a Grant Proposal: This report is intended for Members and staff assisting grant seekers in districts and states and covers writing proposals for both government and private foundations grants. In preparation for writing a proposal, the report first discusses preliminary information gathering and preparation, developing ideas for the proposal, gathering community support, identifying funding resources, and seeking preliminary review of the proposal and support of relevant administrative officials. The second section of the report covers the actual writing of the proposal. The last section of the report provides a listing of free grants-writing websites.
The U.S. Science and Technology Workforce: This report provides an overview of the status of the U.S. science and technology (S&T) workforce, and identifies some of the issues and options that are currently being discussed in Congress. The report concludes with a summary of some pertinent activities in the 110th Congress.
U.S. National Science Foundation: Experimental Program to Stimulate Competitive Research (EPSCoR): This report discusses current policy involving the Experimental Program to Stimulate Competitive Research (EPSCoR) of the National Science Foundation (NSF), as well as budget requests.
The Advanced Spectroscopic Portal Program: Background and Issues for Congress: This report provides an overview of the Advanced Spectroscopic Portal (ASP) program's history and outlines issues for Congress as the program moves forward. The ASP is an improved type of radiation detection device, meant to serve as part of new and existing programs to protect against terrorist nuclear or radiological attack.
Technology Transfer: Use of Federally Funded Research and Development: This report discusses the federal use of technology transfer, a process by which technology developed in one organization, in one area, or for one purpose is applied in another organization, in another area, or for another purpose.
Commerce, Justice, Science, and Related Agencies: FY2010 Appropriations: This report provides an overview of actions taken by Congress to provide FY2011 appropriations for Commerce, Justice, Science, and Related Agencies (CJS). It also provides an overview of FY2010 appropriations for agencies and bureaus funded under the CJS bill.
Technology Transfer: Use of Federally Funded Research and Development: This report discusses the federal use of technology transfer, a process by which technology developed in one organization, in one area, or for one purpose is applied in another organization, in another area, or for another purpose.
Counterterrorism Research and Development: Funding, Priority-setting, and Coordination: This report describes the basic R&D issues that concern the adequacy of planning/coordination mechanisms, including those in the Office of Science and Technology Policy and Office of Homeland Security; which counterterrorism R&D should be transferred to a new department; and how other R&D counterterrorism activities that are not transferred should be coordinated.
Counterterrorism Research and Development: Funding, Priority-setting, and Coordination: This report describes the basic R&D issues concern regarding the adequacy of planning/coordination mechanisms, including those in the Office of Science and Technology Policy and Office of Homeland Security; which counterterrorism R&D should be transferred to a new department; and how other R&D counterterrorism activities that are not transferred should be coordinated.
Science, Technology, and Medicine: Issues Facing the 106th Congress, Second Session: No Description Available.
An Examination of the Issues Surrounding Biotechnology Patenting and Its Effect Upon Entrepreneurial Companies: The biotechnology industry is notable both for its heavy concentration of small businesses and its weighty research and development (R&D) expenditures. Given the small size and heavy expenses of many biotechnology firms, their ability to raise venture capital may be of some consequence. The patent law has been identified as a facilitator of these R&D financing efforts. Congress may choose to exercise oversight on these issues. Such consideration would likely include examination of U.S. commitments in international agreements along with other factors.
Stem Cell Research: Embryonic stem cells have the ability to develop into virtually any cell in the body, and they may have the potential to treat medical conditions such as diabetes and Parkinson’s disease. In August 2001, President Bush announced that for the first time federal funds would be used to support research on human embryonic stem cells, but funding would be limited to “existing stem cell lines.” The National Institutes of Health (NIH) has established the Human Embryonic Stem Cell Registry, which lists 78 stem cell lines that are eligible for use in federally funded research. However, only 22 embryonic stem cell lines are currently available. Scientists are concerned about the quality, and longevity of these stem cell lines.
Stem Cell Research: Embryonic stem cells have the ability to develop into virtually any cell in the body and they may have the potential to treat medical conditions such as diabetes and Parkinson’s disease. In August 2001, President Bush announced that for the first time federal funds would be used to support research on human embryonic stem cells, but funding would be limited to “existing stem cell lines.”
Homeland Security Research and Development Funding, Organization, and Oversight: P.L. 107-296, the Homeland Security Act, consolidated some research and development (R&D) in the Department of Homeland Security (DHS), whose FY2006 R&D budget was requested at $1.368 billion, about 4% more than FY2005, enacted. The House passed H.R. 1817, an FY2006 authorization bill, which would expand DHS’s R&D, and H.R. 2360, which would appropriate $1.340 billion for these activities. Senate action is pending. DHS is mandated to coordinate all federal agency homeland security R&D, which was requested at $4.0 billion. Policy issues relating to DHS’s R&D includes priority-setting, eliminating possible waste in technology programs, performance monitoring, and interagency coordination. This report will be updated.
National Environmental Education Act of 1990: Overview, Implementation, and Reauthorization Issues: This report presents an overview of the National Environmental Education Act of 1990, discusses appropriations, examines Environmental Protection Agency (EPA's) implementation of the act, and analyzes potential issues for reauthorization that may be considered in the 109th Congress.
Federal Research and Development Funding: FY2005: This report discusses federal research and development (R&D) funding for FY2005. The Bush Administration requested $131.9 billion in R&D funding for FY2005. This was $5.9 billion above the estimated $126 billion that was appropriated for federal R&D in FY2004.
National Environmental Education Act of 1990: Overview, Implementation, and Reauthorization Issues: This report presents an overview of the National Environmental Education Act of 1990, discusses appropriations, examines Environmental Protection Agency (EPA's) implementation of the act, and analyzes potential issues for reauthorization that may be considered in the 109th Congress.
Background and Legal Issues Related to Stem Cell Research: In August 2001, President Bush announced that federal funds, with certain restrictions, may be used to conduct research on human embryonic stem cells. This report explains the limitations on this research, as well as corresponding and related legislation to the issue of embryonic stem cell research, including the Stem Cell Research Enhancement Act of 2005.
Homeland Security Research and Development Funding, Organization, and Oversight: The Homeland Security Act consolidated some research and development (R&D) in the Department of Homeland Security (DHS), whose FY2007 R&D budget (excluding management/procurement) was requested at $1.1 billion, about 10% less than FY2006, and represents the first decline in DHS's R&D funding since the agency started funding R&D in 2002. DHS is mandated to coordinate all federal agency homeland security R&D, which was requested at about $5.1 billion. This report lists related legislation and policy issues relating to DHS's R&D programs.
National Environmental Education Act of 1990: Overview, Implementation, and Reauthorization Issues: No Description Available.
Background and Legal Issues Related to Stem Cell Research: In August 2001, President Bush announced that federal funds, with certain restrictions, may be used to conduct research on human embryonic stem cells. Federal research is limited to “the more than 60” existing stem cell lines that were derived (1) with the informed consent of the donors; (2) from excess embryos created solely for reproductive purposes; and (3) without any financial inducements to the donors. No federal funds may be used for the derivation or use of stem cell lines derived from newly destroyed embryos; the creation of any human embryos for research purposes; or cloning of human embryos for any purposes.
Federal Research and Development Funding: FY2006: This report discusses federal research and development (R&D) funding. The Bush Administration has requested $132.2 billion in federal research and development (R&D) funding for FY2006. This sum represents a $505 million increase over the FY2005 estimated funding level of $131.7 billion. In real dollars, total federal R&D would decline for the first time since FY1996.
Federal Research and Development Funding: FY2007: This report discusses federal research and development (R&D) funding. The Bush Administration requested $137.2 billion in R&D funding for FY2007. This sum represents a 2.6% increase over the estimated $133.7 billion that was approved in FY2006. As in the recent past, the FY2007 increase over the FY2006 estimated funding levels is due to significant funding increases in the Department of Defense (DOD) and the National Aeronautics and Space Administration’s (NASA’s) space vehicles development program.
Cooperative R&D: Federal Efforts to Promote Industrial Competitiveness: In response to the foreign challenge in the global marketplace, the United States Congress has explored ways to stimulate technological advancement in the private sector. The government has supported various efforts to promote cooperative research and development activities among industry, universities, and the federal R&D establishment designed to increase the competitiveness of American industry and to encourage the generation of new products, processes, and services.
Cooperative R&D: Federal Efforts to Promote Industrial Competitiveness: In response to the foreign challenge in the global marketplace, the United States Congress has explored ways to stimulate technological advancement in the private sector. The government has supported various efforts to promote cooperative research and development activities among industry, universities, and the federal R&D establishment designed to increase the competitiveness of American industry and to encourage the generation of new products, processes, and services.
Background and Legal Issues Related to Stem Cell Research: In August 2001, President Bush announced that federal funds, with certain restrictions, may be used to conduct research on human embryonic stem cells. Federal research is limited to “the more than 60” existing stem cell lines that were derived (1) with the informed consent of the donors; (2) from excess embryos created solely for reproductive purposes; and (3) without any financial inducements to the donors. No federal funds may be used for the derivation or use of stem cell lines derived from newly destroyed embryos; the creation of any human embryos for research purposes; or cloning of human embryos for any purposes.
Homeland Security Research and Development Funding, Organization, and Oversight: The Homeland Security Act consolidated some research and development (R&D) in the Department of Homeland Security (DHS), whose FY2007 R&D budget (excluding management/procurement) was requested at $1.1 billion, about 10% less than FY2006, and represents the first decline in DHS's R&D funding since the agency started funding R&D in 2002. DHS is mandated to coordinate all federal agency homeland security R&D, which was requested at about $5.1 billion. This report lists related legislation and policy issues relating to DHS's R&D programs.
Federal Research and Development Funding: FY2006: This report discusses federal research and development (R&D) funding. The Bush Administration requested $132.4 billion in R&D funding for FY2006. This sum represents a $400 million increase over the FY2005 estimated funding level of $132 billion.
Science and Technology Policymaking: A Primer: This report provides a basic understanding of science and technology policy including the nature of S&T policy, how scientific and technical knowledge is useful for public policy decisionmaking, and an overview of the key stakeholders in science and technology policy.
Science, Technology, and American Diplomacy: Background and Issues for Congress: This report provides an overview of current U.S. international S&T policy; describes the role of the Department of State (DOS), the White House Office of Science and Technology Policy (OSTP), the U.S. Agency for International Development (USAID), and other federal agencies; and discusses possible policy options for Congress. It focuses on international science and technology diplomacy, where American leadership in science and technology is used as a diplomatic tool to enhance another country's development and to improve understanding by other nations of U.S. values and ways of doing business.
Federal R&D Funding Under a Continuing Resolution: This report discusses the continuing resolution, or CR (P.L. 109-383, H.J.Res. 102) which provides spending at FY2006 levels (through February 15, 2007), for those agencies lacking enacted FY2007 appropriations bills.
Nanotechnology: A Policy Primer: This report provides an overview of nanotechnology, nanomanufacturing, and public understanding of and attitudes toward nanotechnology. Congress has demonstrated continuing support for nanotechnology and has directed its attention primarily to three topics that may affect the realization of this hoped for potential: federal research and development (R&D) in nanotechnology; U.S. competitiveness; and environmental, health, and safety (EHS) concerns.
Minority Rights and Senate Procedures: This report discusses the nature of Senate procedures and various opportunities that the minority has to influence the process. The rules of the Senate emphasize the rights and prerogatives of individual Senators and, therefore, minority groups of Senators. The Senate's rules also are a source of other minority rights, including the right to propose non-germane amendments to most bills and to prevent bills from being referred to committees that might not consider and report them.
Federal R&D, Drug Discovery, and Pricing: Insights from the NIH-University-Industry Relationship: This report explores the reasons behind government funding of research and development and subsequent efforts to facilitate private sector commercialization of the results of such work, without addressing issues associated with drug costs or pricing. It particularly looks at the manner in which the National Institutes of Health (NIH) supports research to encourage the development of new pharmaceuticals and therapeutics, particularly through cooperative activities among academia, industry, and government.
Patent Ownership and Federal Research and Development (R and D): A Discussion on the Bayh-Dole Act and the Stevenson-Wydler Act: Two major laws govern the dispensation of patents associated with federal research and development (R&D) activities. Both P.L. 96-418, the Stevenson-Wydler Technology Innovation Act, as amended, and P.L. 96-517, Amendments to the Patent and Trademark Act (commonly referred to as "Bayh-Dole" after its two main sponsors, former Senators Birch Bayh and Robert Dole), are the foundation for efforts to utilize patent ownership to encourage the commercialization of technologies and techniques that have their roots in the federal R&D enterprise
Possible Impacts of Major Counter Terrorism Security Actions on Research, Development, and Higher Education: No Description Available.
The National Ignition Facility: Management, Technical, and Other Issues: No Description Available.
Federal R&D, Drug Discovery, and Pricing: Insights from the NIH-University-Industry Relationship: Interest in methods to provide drugs at lower cost, particularly for the elderly, has rekindled discussion over the role the federal government plays in facilitating the creation of new pharmaceuticals for the marketplace. This report explores the issue of whether or not the substantial federal investment in health-related research and development (R&D) entitles the public to commensurate consideration in prices charged for any resulting drugs. It is intended to provide the reader with an understanding of the rationale for government support of R&D and subsequent efforts to facilitate private sector commercialization of new technologies generated from such work. Concerns surrounding innovation in pharmaceuticals and biotechnology are discussed within the broader context of the federal role in facilitating technological progress.
U.S. National Science Foundation: An Overview: No Description Available.
Federal Research and Development Funding: FY2010: This report summarizes the FY2010 budget request for research & development (R&D) funding, including comparisons to R&D funding requests in the FY2009 budget. Congress will play a central role in defining the nation's R&D priorities, especially with respect to two overarching issues: the extent to which the Federal R&D investment can grow in the context of increased pressure on discretionary spending and how available funding will be prioritized and allocated. This report breaks down in detail the various aspects of the President's FY2010 R&D funding request.
Foreign Science and Engineering Presence in U.S. Institutions and the Labor Force: This report discusses the increased presence of foreign students in graduate science and engineering programs and in the scientific workforce that has been and continues to be of concern to some in the scientific community. Enrollment of U.S. citizens in graduate science and engineering programs has not kept pace with that of foreign students in those programs. Many in the scientific community maintain that in order to compete with countries that are rapidly expanding their scientific and technological capabilities, the country needs to bring to the United States those whose skills will benefit society and will enable us to compete in the new-technology based global economy. This report analyzes this issue in detail and includes discussion of related legislation.
The America COMPETES Act and the FY2009 Budget: This report discusses in detail the America COMPETES Act, including the funding increases authorized by the act for various relevant institutions; the act's education activities intended to enhance the skills of STEM educators; and if Congress will continue to similarly fund the America COMPETES Act in the FY2010 budget.
Federal Research and Development Funding: FY2010: This report summarizes the FY2010 budget request for research & development (R&D) funding, including comparisons to R&D funding requests in the FY2009 budget. This report breaks down in detail the various aspects of the President's FY2010 R&D funding request.

Congressional Research Service Reports - 328 Matching Results

Search Results

Add Filters

Applied Filters